REPL vs VRTX: Which Stock is Better?
Side-by-side comparison of Replimune Group Inc and Vertex Pharmaceuticals Inc in 2026
REPL
Replimune Group Inc
—
VRTX
Vertex Pharmaceuticals Inc
$475.20
Key Metrics Comparison
| Metric | REPL | VRTX | Winner |
|---|---|---|---|
| Market Cap | $825.73M | $106.87B | VRTX |
| P/E Ratio | N/A | 29.67 | VRTX |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze REPL
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REPL or VRTX a better investment?
Comparing REPL and VRTX: Replimune Group Inc has a market cap of $825.73M while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REPL and VRTX?
REPL (Replimune Group Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REPL or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: REPL or VRTX?
Both REPL and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: REPL or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: REPL or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $825.73M for REPL.
Should I buy REPL or VRTX in 2026?
Both REPL and VRTX have investment merit. REPL trades at $N/A while VRTX trades at $475.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REPL and VRTX stock?
Key differences: Market Cap ($825.73M vs $106.87B), P/E Ratio (N/A vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy REPL or VRTX in 2026?
The choice between REPL and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between REPL and VRTX?
REPL (Replimune Group Inc) has a market cap of $825.73M, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.